175 related articles for article (PubMed ID: 7297018)
1. Kinetics and renal handling of cefonicid.
Pitkin D; Dubb J; Actor P; Alexander F; Ehrlich S; Familiar R; Stote R
Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
[TBL] [Abstract][Full Text] [Related]
2. Azlocillin and cefonicid penetration into bone enhanced by probenecid.
Summersgill JT; Harrod LG; Raff MJ
Antimicrob Agents Chemother; 1984 Sep; 26(3):292-4. PubMed ID: 6508259
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
Neu HC
J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
[TBL] [Abstract][Full Text] [Related]
5. Cefonicid kinetics in subjects with normal and impaired renal function.
Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefonicid in uraemic patients.
Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
[TBL] [Abstract][Full Text] [Related]
8. An overview of pharmacokinetics.
Cutler RE
Rev Infect Dis; 1984; 6 Suppl 4():S803-8. PubMed ID: 6522921
[TBL] [Abstract][Full Text] [Related]
9. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
Fourtillan JB; Leroy A; Lefebvre MA; Humbert G; Fillastre JP; Reumont G; Ramis N
Eur J Drug Metab Pharmacokinet; 1985; 10(3):225-30. PubMed ID: 3936717
[TBL] [Abstract][Full Text] [Related]
10. Ceftizoxime kinetics and renal handling.
Dubb J; Actor P; Pitkin D; Alexander F; Familiar R; Ehrlich S; Stote R
Clin Pharmacol Ther; 1982 Apr; 31(4):516-21. PubMed ID: 6277546
[TBL] [Abstract][Full Text] [Related]
11. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
Phelps RT; Conte JE
Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
[TBL] [Abstract][Full Text] [Related]
12. In vitro experience with cefonicid.
Actor P
Rev Infect Dis; 1984; 6 Suppl 4():S783-90. PubMed ID: 6522920
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cefonicid in children.
Furlanut M; D'Elia R; Riva E; Pasinelli F
Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
[TBL] [Abstract][Full Text] [Related]
14. Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
Dudley MN; Shyu WC; Nightingale CH; Quintiliani R
Antimicrob Agents Chemother; 1986 Oct; 30(4):565-9. PubMed ID: 3789691
[TBL] [Abstract][Full Text] [Related]
15. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Tartaglione TA; Polk RE
Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of cefamandole in patients with reduced renal function.
Czerwinski AW; Pederson JA
Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
[TBL] [Abstract][Full Text] [Related]
17. Use of long half-life parenteral cephalosporins in ambulatory practice.
Sauerwein M; Deamer RL; Prichard JG
J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
[TBL] [Abstract][Full Text] [Related]
18. Ceforanide kinetics.
Estey EH; Weaver SS; LeBlanc BM; Brown N; Ho DH; Bodey GP
Clin Pharmacol Ther; 1981 Sep; 30(3):396-403. PubMed ID: 7273604
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal transport of cefonicid.
Morse GD; Lane T; Nairn DK; Deterding J; Curry J; Gal P
Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
[TBL] [Abstract][Full Text] [Related]
20. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
Wallace RJ; Niefield SL; Waters S; Waters B; Awe RJ; Wiss K; Martin RR; Greenberg SB
Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
